1. Home
  2. EDSA vs HUBC Comparison

EDSA vs HUBC Comparison

Compare EDSA & HUBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • HUBC
  • Stock Information
  • Founded
  • EDSA 2015
  • HUBC 2017
  • Country
  • EDSA Canada
  • HUBC Israel
  • Employees
  • EDSA N/A
  • HUBC N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • HUBC
  • Sector
  • EDSA Health Care
  • HUBC
  • Exchange
  • EDSA Nasdaq
  • HUBC Nasdaq
  • Market Cap
  • EDSA 13.8M
  • HUBC 16.0M
  • IPO Year
  • EDSA N/A
  • HUBC N/A
  • Fundamental
  • Price
  • EDSA $4.30
  • HUBC $0.52
  • Analyst Decision
  • EDSA Strong Buy
  • HUBC
  • Analyst Count
  • EDSA 2
  • HUBC 0
  • Target Price
  • EDSA $39.00
  • HUBC N/A
  • AVG Volume (30 Days)
  • EDSA 10.6K
  • HUBC 708.0K
  • Earning Date
  • EDSA 08-09-2024
  • HUBC 10-15-2024
  • Dividend Yield
  • EDSA N/A
  • HUBC N/A
  • EPS Growth
  • EDSA N/A
  • HUBC N/A
  • EPS
  • EDSA N/A
  • HUBC N/A
  • Revenue
  • EDSA N/A
  • HUBC $42,657,000.00
  • Revenue This Year
  • EDSA N/A
  • HUBC N/A
  • Revenue Next Year
  • EDSA N/A
  • HUBC N/A
  • P/E Ratio
  • EDSA N/A
  • HUBC N/A
  • Revenue Growth
  • EDSA N/A
  • HUBC N/A
  • 52 Week Low
  • EDSA $2.46
  • HUBC $0.44
  • 52 Week High
  • EDSA $8.33
  • HUBC $9.40
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 48.15
  • HUBC 45.24
  • Support Level
  • EDSA $4.13
  • HUBC $0.49
  • Resistance Level
  • EDSA $4.44
  • HUBC $0.67
  • Average True Range (ATR)
  • EDSA 0.22
  • HUBC 0.06
  • MACD
  • EDSA -0.00
  • HUBC 0.00
  • Stochastic Oscillator
  • EDSA 25.29
  • HUBC 31.97

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.

About HUBC Hub Cyber Security Ltd.

Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.

Share on Social Networks: